The Hindu Businessline

FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning

These drugs may be associated with a drop in blood flow to the optic nerve which can cause sudden, painless loss of vision in one eye, and sometimes the damage is permanent, FDA said